AI Tokens
Stock Analysis on Net

McKesson Corp. (NYSE:MCK)

This company has been moved to the archive! The financial data has not been updated since October 27, 2016.

Common Stock Valuation Ratios (Price Multiples)

Microsoft Excel

Current Valuation Ratios

McKesson Corp., current price multiples

Microsoft Excel
McKesson Corp. Abbott Laboratories Elevance Health Inc. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc.
Selected Financial Data
Current share price (P) $160.50
No. shares of common stock outstanding 226,086,960
Growth rate (g) 17.08%
 
Earnings per share (EPS) $9.99
Next year expected EPS $11.69
Operating profit per share $15.68
Sales per share $844.29
Book value per share (BVPS) $39.47
Valuation Ratios (Price Multiples)
Price to earnings (P/E) 16.07 30.13 16.48 56.87 27.93 29.41
Price to next year expected earnings 13.73 27.94 14.74 49.86 27.56 26.20
Price-earnings-growth (PEG) 0.94 3.84 1.39 4.05 20.39 2.40
Price to operating profit (P/OP) 10.24 24.41 14.20 55.14 20.74 18.70
Price to sales (P/S) 0.19 4.43 0.47 16.14 3.69 0.80
Price to book value (P/BV) 4.07 3.77 2.13 9.11 2.71 3.77

Based on: 10-K (reporting date: 2016-03-31).

If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.


Historical Valuation Ratios (Summary)

McKesson Corp., historical price multiples

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Price to earnings (P/E) 17.21 36.01 32.53 18.40 15.13 17.38
Price to operating profit (P/OP) 10.96 17.91 17.36 10.63 9.88 11.47
Price to sales (P/S) 0.20 0.30 0.30 0.20 0.17 0.19
Price to book value (P/BV) 4.35 6.64 4.82 3.48 3.11 2.89

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).


The valuation multiples from 2011 to 2016 exhibit a distinct cycle of stability, rapid expansion, and subsequent contraction. A significant peak in valuation is observed during the 2014 and 2015 fiscal years across all measured metrics, followed by a sharp correction in 2016 that returned most ratios to levels comparable to the 2011-2013 period.

Earnings and Operating Profit Multiples
The Price to earnings (P/E) and Price to operating profit (P/OP) ratios demonstrate a highly correlated trend. Both ratios remained relatively stable between 2011 and 2013, with P/E fluctuating between 15.13 and 18.40. A substantial upward shift occurred in 2014, with the P/E ratio climbing to 32.53 and peaking at 36.01 in 2015. This expansion indicates a period of significantly higher market premiums on earnings. However, this trend reversed abruptly in 2016, as the P/E ratio fell to 17.21, effectively neutralizing the gains seen in the preceding two years.
Revenue Valuation
The Price to sales (P/S) ratio remained consistently low throughout the period, reflecting a business model characterized by high revenue volume relative to market capitalization. The ratio stayed within a narrow range of 0.17 to 0.20 from 2011 to 2013, rose to a plateau of 0.30 during 2014 and 2015, and subsequently returned to 0.20 by March 31, 2016.
Book Value Expansion and Correction
The Price to book value (P/BV) ratio showed the most consistent growth trend prior to the 2016 correction. Starting at 2.89 in 2011, the ratio increased steadily each year, reaching a peak of 6.64 in 2015. This suggests a growing market premium over the company's net asset value over five years. This trend culminated in a significant decline in 2016, with the ratio dropping to 4.35, though it remained higher than the baseline levels observed between 2011 and 2013.

Overall, the data reveals a synchronized movement in valuation multiples. The sharp increase in all ratios during 2014-2015 suggests a period of aggressive valuation expansion, while the 2016 results indicate a market correction that realigned the stock price more closely with historical earnings and sales multiples.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Price to Earnings (P/E)

McKesson Corp., historical P/E calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
No. shares of common stock outstanding1 225,020,523 231,553,531 230,576,753 226,611,092 235,397,188 252,120,037
Selected Financial Data (US$)
Net income attributable to McKesson Corporation (in millions) 2,258 1,476 1,263 1,338 1,403 1,202
Earnings per share (EPS)2 10.03 6.37 5.48 5.90 5.96 4.77
Share price1, 3 172.70 229.55 178.20 108.63 90.17 82.84
Valuation Ratio
P/E ratio4 17.21 36.01 32.53 18.40 15.13 17.38
Benchmarks
P/E Ratio, Competitors5
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 Data adjusted for splits and stock dividends.

2 2016 Calculation
EPS = Net income attributable to McKesson Corporation ÷ No. shares of common stock outstanding
= 2,258,000,000 ÷ 225,020,523 = 10.03

3 Closing price as at the filing date of McKesson Corp. Annual Report.

4 2016 Calculation
P/E ratio = Share price ÷ EPS
= 172.70 ÷ 10.03 = 17.21

5 Click competitor name to see calculations.


The analysis of valuation multiples between 2011 and 2016 reveals a period of significant price volatility and valuation expansion followed by a sharp correction.

Share Price Dynamics
A consistent upward trend in share price is evident from 2011 through 2015, rising from 82.84 to a peak of 229.55. This growth trajectory reversed in 2016, with the share price declining to 172.70.
Earnings Performance
Earnings per share exhibited an overall upward trajectory, although growth was non-linear. Following a period of relative stagnation and a slight dip between 2012 and 2014, a substantial acceleration occurred in 2016, where earnings per share rose to 10.03, the highest value in the observed period.
Price-to-Earnings (P/E) Ratio Trends
The P/E ratio transitioned through three distinct phases. From 2011 to 2013, the multiple remained relatively stable, fluctuating between 15.13 and 18.40. A phase of aggressive valuation expansion occurred in 2014 and 2015, during which the ratio more than doubled to reach a peak of 36.01. This indicates that share price appreciation significantly outpaced earnings growth during these two years. In 2016, a sharp contraction occurred, returning the P/E ratio to 17.21. This normalization was the result of a simultaneous decrease in share price and a significant increase in earnings per share.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Price to Operating Profit (P/OP)

McKesson Corp., historical P/OP calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
No. shares of common stock outstanding1 225,020,523 231,553,531 230,576,753 226,611,092 235,397,188 252,120,037
Selected Financial Data (US$)
Operating income (in millions) 3,545 2,968 2,367 2,315 2,149 1,821
Operating profit per share2 15.75 12.82 10.27 10.22 9.13 7.22
Share price1, 3 172.70 229.55 178.20 108.63 90.17 82.84
Valuation Ratio
P/OP ratio4 10.96 17.91 17.36 10.63 9.88 11.47
Benchmarks
P/OP Ratio, Competitors5
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 Data adjusted for splits and stock dividends.

2 2016 Calculation
Operating profit per share = Operating income ÷ No. shares of common stock outstanding
= 3,545,000,000 ÷ 225,020,523 = 15.75

3 Closing price as at the filing date of McKesson Corp. Annual Report.

4 2016 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 172.70 ÷ 15.75 = 10.96

5 Click competitor name to see calculations.


The analysis of valuation multiples between March 31, 2011, and March 31, 2016, reveals a divergence between the steady growth of operating performance and the volatility of the equity market's valuation of that performance.

Operating Profit per Share Trend
A consistent and uninterrupted upward trend in operating profit per share is observed over the six-year period. The value grew from 7.22 US$ in 2011 to 15.75 US$ in 2016, representing a sustained increase in fundamental operational efficiency.
Share Price Movement
The share price experienced significant fluctuations, contrasting with the steady profit growth. After a period of moderate growth between 2011 and 2013, a sharp acceleration occurred in 2014 and 2015, with the price peaking at 229.55 US$. A substantial correction followed in 2016, with the price descending to 172.70 US$.
Price to Operating Profit (P/OP) Ratio Analysis
The P/OP ratio exhibited three distinct phases. From 2011 to 2013, the multiple remained relatively stable, fluctuating between 9.88 and 11.47. A period of significant valuation expansion occurred in 2014 and 2015, where the ratio spiked to 17.36 and 17.91, respectively, indicating that the share price was increasing at a rate far exceeding the growth in operating profit. By 2016, the ratio contracted sharply to 10.96, returning to levels consistent with the 2011-2013 period.

The data suggests that while the operational foundation of the company strengthened consistently through 2016, the market valuation experienced a period of inflation between 2014 and 2015, followed by a normalization in 2016 where the P/OP ratio realigned with historical norms despite record-high operating profits per share.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Price to Sales (P/S)

McKesson Corp., historical P/S calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
No. shares of common stock outstanding1 225,020,523 231,553,531 230,576,753 226,611,092 235,397,188 252,120,037
Selected Financial Data (US$)
Revenues (in millions) 190,884 179,045 137,609 122,455 122,734 112,084
Sales per share2 848.30 773.23 596.80 540.38 521.39 444.57
Share price1, 3 172.70 229.55 178.20 108.63 90.17 82.84
Valuation Ratio
P/S ratio4 0.20 0.30 0.30 0.20 0.17 0.19
Benchmarks
P/S Ratio, Competitors5
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 Data adjusted for splits and stock dividends.

2 2016 Calculation
Sales per share = Revenues ÷ No. shares of common stock outstanding
= 190,884,000,000 ÷ 225,020,523 = 848.30

3 Closing price as at the filing date of McKesson Corp. Annual Report.

4 2016 Calculation
P/S ratio = Share price ÷ Sales per share
= 172.70 ÷ 848.30 = 0.20

5 Click competitor name to see calculations.


The valuation metrics indicate a period of consistent revenue growth per share accompanied by significant volatility in share price between 2011 and 2016. While the operational performance showed a steady upward trajectory, the market valuation reflected fluctuating investor sentiment, as evidenced by the shifts in the price-to-sales (P/S) multiple.

Sales per Share Performance
A continuous upward trend is observed in sales per share, which increased from 444.57 in 2011 to 848.30 by 2016. This consistent growth demonstrates a sustained expansion in revenue generation relative to the shares outstanding over the six-year period.
Share Price Movement
The share price experienced an overall increase from 82.84 in 2011 to a peak of 229.55 in 2015. The most significant acceleration occurred between 2013 and 2015, followed by a sharp contraction in 2016, where the price declined to 172.70.
Price-to-Sales (P/S) Ratio Analysis
The P/S ratio remained relatively low throughout the analyzed period, ranging from a minimum of 0.17 in 2012 to a maximum of 0.30 in 2014 and 2015. The expansion of the ratio to 0.30 during 2014 and 2015 suggests a period where the market price appreciated at a rate exceeding the growth of sales. In 2016, the ratio contracted to 0.20, a result of the share price correction occurring simultaneously with continued growth in sales per share.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Price to Book Value (P/BV)

McKesson Corp., historical P/BV calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
No. shares of common stock outstanding1 225,020,523 231,553,531 230,576,753 226,611,092 235,397,188 252,120,037
Selected Financial Data (US$)
Total McKesson Corporation stockholders’ equity (in millions) 8,924 8,001 8,522 7,070 6,831 7,220
Book value per share (BVPS)2 39.66 34.55 36.96 31.20 29.02 28.64
Share price1, 3 172.70 229.55 178.20 108.63 90.17 82.84
Valuation Ratio
P/BV ratio4 4.35 6.64 4.82 3.48 3.11 2.89
Benchmarks
P/BV Ratio, Competitors5
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 Data adjusted for splits and stock dividends.

2 2016 Calculation
BVPS = Total McKesson Corporation stockholders’ equity ÷ No. shares of common stock outstanding
= 8,924,000,000 ÷ 225,020,523 = 39.66

3 Closing price as at the filing date of McKesson Corp. Annual Report.

4 2016 Calculation
P/BV ratio = Share price ÷ BVPS
= 172.70 ÷ 39.66 = 4.35

5 Click competitor name to see calculations.


The valuation of the common stock relative to its book value exhibited a consistent upward trajectory from 2011 through 2015, followed by a significant correction in 2016. During the growth phase, the market price of the stock appreciated at a rate that substantially outpaced the growth of the company's book value per share, leading to an expansion of the valuation multiple.

Share Price and Book Value Trends
Share prices rose steadily from 82.84 US$ in 2011 to a peak of 229.55 US$ in 2015. In comparison, the book value per share demonstrated more moderate growth, increasing from 28.64 US$ in 2011 to 39.66 US$ by 2016. A slight contraction in book value per share was noted in 2015, dropping to 34.55 US$ from the previous year's 36.96 US$.
P/BV Ratio Expansion
The P/BV ratio increased from 2.89 in 2011 to 6.64 in 2015. The most pronounced acceleration occurred between 2013 and 2015, during which the ratio climbed from 3.48 to 6.64, indicating a significant increase in the premium the market was willing to pay over the accounting value of the equity.
Valuation Correction in 2016
A sharp decline in the P/BV ratio to 4.35 is observed in 2016. This contraction was driven by a decrease in the share price to 172.70 US$, which occurred despite the book value per share reaching its highest point in the analyzed period at 39.66 US$.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?